Stock Analiz

111, Inc. YI

Retail-Drug Stores and Proprietary Stores · IPO 2018 · data as of November 13, 2026

$2.84Market cap $25M
Open the interactive analysis →

111, Inc. (YI) is a consumer staples company listed in the US with a market value of about $25M. In fiscal year 2025 it had revenue of $1.8B and net income of -$9M, a net margin of -0.5%.

Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is financial health (3/5); the weakest is track record (0/5).

Key numbers: a price to free cash flow of 1.5, 5-year revenue growth of 7% a year, a 5-year average ROIC of -202%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 1511% above the current price.

About 111

111 is listed in the US and classified in retail-drug stores and proprietary stores, IPO year 2018. Revenue went from $260M in 2018 to $1.8B in 2025, growth of about 31.8% a year. It was profitable in 0 of the last 10 years in our data.

Score: 1.4 / 5

Value2/5
Future growth1/5
Track record0/5
Financial health3/5
Shareholder returns1/5

Checks passed

  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • Profit margin improving
  • More cash than debt, or low debt to equity
  • Positive free cash flow
  • Debt below 3 years of free cash flow
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF1.5
P/S0.0
P/B—
EV/EBITDA-15.8
PEG—
Dividend yield0.00%
FCF yield65.6%
Shareholder yield0.0%
Intrinsic value vs. price+1511%

Growth and quality

Revenue growth (1 yr)-9.0%
Revenue growth (5 yrs, per year)7.4%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-2.4%
ROIC (5-yr avg.)-201.7%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal year2025202420232022202120202019201820172016
Revenue$1.8B$2.0B$2.1B$2.0B$1.9B$1.3B$568M$260M——
Net income-$9M-$9M-$55M-$60M-$105M-$70M-$72M-$56M-$38M-$52M
Free cash flow$16M$34M-$64M-$8M-$118M-$22M-$76M-$52M——
EPS (diluted)$-1.08$-1.01$-6.29$-6.87$-11.95$-7.95$-8.16$-6.31$-4.36$-5.95
Net margin-0.5%-0.4%-2.6%-3.1%-5.4%-5.6%-12.6%-21.4%——
ROIC————-201.7%-54.5%-40.6%-24.6%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is 111 stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 1511% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does 111 pay a dividend?

Not currently.

Is 111 a good stock to buy?

We do not give buy or sell advice. 111 scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.